Jul 24, 2026
NovoCure (NVCR) Stock Soars 28% on Milestone Quarter and Strong Revenue Forecast
NovoCure (NVCR) stock rallied 28% after posting record Q2 revenue of $183.6M, positive EBITDA, and raising 2026 guidance. Full analysis inside.
The post NovoCure (NVCR) Stock Soars 28% on Milestone Quarter and Strong Revenue Forecast appeared first on Blockonomi.
Source: Blockonomi →Related News
- 4 hours ago
AbCellera (ABCL) Stock Surges 6% on Menopause Treatment Phase 2 Data Reveal
- 4 hours ago
Tempus AI (TEM) Stock Soars 11% on Groundbreaking Cancer AI Study and Quarterly...
- 4 hours ago
Uber (UBER) Stock Surges on Q2 Earnings Beat: Is the Rally Sustainable?
- 6 hours ago
QuantumScape (QS) Stock Surges 16.5% This Week Despite Lack of News
- 6 hours ago
Westwater Resources (WWR) Stock Soars 88% on $25M Federal Financing Deal